Boston Scientific Corp.

NYSE:BSX  
43.40
+0.15 (+0.35%)
5:06:29 PM EDT: $43.51 +0.11 (+0.25%)
Products, Regulatory

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data For The Ranger Drug-Coated Balloon

Published: 10/05/2021 17:15 GMT
Boston Scientific Corp. (BSX) - Boston Scientific Announces Positive Late-breaking Clinical Trial Data for the Ranger™ Drug-coated Balloon.
Boston Scientific - Two-year Data Demonstrate Continued High Rates of Primary Patency Including in Patients With Complex Lesions.
Boston Scientific - Ranger Dcb, Which Has Low Drug Dose Density of Paclitaxel, Also Demonstrated Significant Reduction in Reinterventions at Two Years.